Form 4: Astrana Health Director Mitchell Kitayama Executes Stock Option and Disposes of Shares

Astrana Health director Mitchell Kitayama exercised stock options and disposed of shares, resulting in a change in his beneficial ownership.

Summary

• Mitchell Kitayama, a director at Astrana Health, executed a stock option to acquire 3,409 shares of common stock at a price of $18.41 on November 22, 2024.
• Following the exercise of the stock option, Mr. Kitayama disposed of 1,490 shares of common stock at a price of $42.11 on the same day.
• After these transactions, Mr. Kitayama's direct holdings decreased to 19,711 shares of common stock.
• The reported holdings include 6,750 shares of restricted stock vesting on December 9, 2024, and 3,564 shares of restricted stock vesting on August 13, 2025, or the date of the 2025 annual meeting.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider transactions, with no inherent positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transactions are typical for directors who receive stock options as part of their compensation.
• The vesting schedules for restricted stock are also common practice to align director interests with long-term company performance.

Stakeholder Impact

• The transactions may have a minor impact on the stock price due to the director's trading activity, but it is not expected to be significant.

Key Dates

Keywords

stock options, insider trading, beneficial ownership, Form 4, Astrana Health, ASTH, director, restricted stock